How the study of the common honeybee is revolutionising the fields of neurobiology and robotics.

Queensland researcher Richard Sturm is looking at how various alleles interact to influence eye, hair and skin colour. The research is of particular importance in understanding skin cancer risk in European populations.

Clinuvel Pharmaceuticals is heading into further Phase II and beginning Phase III trials for several UV-related indications for its photo-protective drug CUV1647. The big hope, however, is its potential to protect organ transplant recipients.

Differences in anti-oxidant levels between males and females may be why men are more likely to develop skin cancer, American researchers report.

In addition to its job as master regulator of apoptosis, p53 is also responsible for activating the tanning response in skin, a new study claims.

The first direct evidence that early Europeans were unable to digest milk has been found by scientists at University College London (UCL) and Mainz University in Germany.

Clinuvel receives regulatory approval for clinical trials for its photo-protective drug CUV1647.

A team of international scientists has just found the most important molecule in human fertility since the discovery of GnRH.

Clinuvel Pharmaceuticals has entered into a heads of agreement with Genepharm Australasia for the sale of Clinuvel's EpiPharm range of pharmaceutical products.

As new Australian restrictions on use of the treated-pine preservative copper-chrome arsenate (CCA) white-ant the profits of New Zealand's arsenic industry, stakeholders in Brisbane biopesticide company BioProspect (ASX:BPO) have cause for optimism.

BioTech Capital (ASX:BTC) has reduced its shareholding in Clinical Cell Culture (ASX:CCE, C3) from about 19 per cent to 12 per cent.